Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 12.69
-0.06 (-0.47%)
Jan 16, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 640.06 million as of January 16, 2026. Its market cap has increased by 6.88% in one year.
Market Cap
640.06M
Enterprise Value
416.48M
Revenue
95.02M
Ranking
n/a
PE Ratio
17.76
Stock Price
12.69
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 640.06M, an increase of 12,148.38%. That is a compound annual growth rate of 21.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 640.06M | 2.33% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.51B |
| Pro Medicus | 21.56B |
| Cochlear | 17.49B |
| Sonic Healthcare | 11.51B |
| Ramsay Health Care | 8.47B |
| Ansell | 4.84B |
| Telix Pharmaceuticals | 3.78B |
| Mesoblast | 3.48B |